Skip to Main Content
Cary Gross
DownloadHi-Res Photo

Cary Gross, MD

Professor of Medicine (General Medicine) and of Epidemiology (Chronic Diseases); Founder and Director, Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, Yale School of Medicine; Director, Adult Primary Care Center, Quality Improvement; Chair, National Clinician Scholars Program; Director, National Clinician Scholars Program

Contact Information

Cary Gross, MD

Patient Care Location

Office Location

Mailing Address

  • General Internal Medicine

    PO Box 208056, 333 Cedar Street

    New Haven, CT, 06520-8056

    United States

COPPER Center

Related Links

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile
Cary Gross
DownloadHi-Res Photo

Appointments

Biography

Dr. Cary Gross is a Professor of Medicine, and Director of the National Clinician Scholars Program at Yale. Dr. Gross completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center and served as chief medical resident at Memorial Sloan-Kettering Cancer Center the following year.His research addresses comparative effectiveness, quality, and population health, with a focus on cancer prevention and treatment. He is a founding Director of Yale’s Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER). His research has been supported by the National Cancer Institute, the Agency for Healthcare Research and Quality, and the American Cancer Society, among others. As a former Robert Wood Johnson Foundation Clinical Scholar, Dr. Gross has advanced training in biostatistics, epidemiology, research ethics, and outcomes research.

Education & Training

  • MD
    New York University School of Medicine (1993)
  • BA
    Johns Hopkins University (1989)
  • Fellow
    Johns Hopkins School of Medicine
  • Chief Resident
    Memorial Sloan-Kettering Cancer Center
  • Resident
    New York Hospital
  • Intern
    New York Hospital, Cornell Medical Center

Activities

  • Geographic Information Systems: Opportunities & Challenges in Cancer Outcomes Research
    Paris, France 2020
  • Understanding Real World Cancer Care and Outcomes: Opportunities for International Collaboration
    Beijing, China 2019
  • Creating and Implementing Clinical Pathways: Where is the Patient Voice?
    San Diego, United States 2019
  • Assessing the Use and Effectiveness of Precision Oncology with Real World Data
    Chicago, United States 2019
  • Innovation & Cancer Care (Panel Discussion)
    New York, United States 2019
  • Contemporary Tumor Registries: What’s Bigger than Big Data?
    Hartford, United States 2019
  • Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma (aUC) at the end of life: Insights from real-world practice. Parikh RB, Galsky M, Gyawali B, Riaz F, Kaufmann T, Cohen A, Adamson B, Gross CP, Meropol N, Mamtani R.
    Chicago, United States 2019
  • Contemporary changes in localized and metastatic prostate cancer incidence by geographic area following decreased PSA screening.
    Chicago, United States 2019
  • Chromosome 1 abnormalities and clinical outcomes in multiple myeloma in the era of novel agents. Giri S, Huntington SF, Wang R, Zeidan AM, Podoltsev N, Gore S, Ma X, Gross CP, Davidoff A, Neparidze N.
    Chicago, United States 2019
  • Affordable Care Act (ACA) Medicaid expansion impact of racial disparities in time to cancer treatment. Adamson B, Cohen A, Estevez M, Magee K, Williams E, Gross CP, Meropol N, Davidoff A.
    Chicago, United States 2019
  • Real-world practice patterns and impact of PD-L1 expression testing in patients with advanced non-small cell lung cancer. Leapman M, Presley C, Zhu W, Soulos P, Adelson K, Boffa D, Gross CP.
    Chicago, United States 2019
  • Impact of an oncology urgent care clinic on emergency department rates. Sedghi T, Canavan M, Gross CP, Davidoff A, Gould Rothberg E, Strait M, Sinanis N, Adelson K.
    Chicago, United States 2019
  • Abandonment trajectories of conventionally fractionated adjuvant radiotherapy in breast cancer care. Xu, X, Gross, CP.
    Chicago, United States 2019
  • Transforming Cancer Screening and Care in the Modern Era: Time to Pump the Brakes?
    New York, United States 2018
  • The Academic Perspective on Real World Evidence
    Washington, United States 2018
  • Is Sharing Clinical Research Data Ready for Prime Time? Lesson’s Learned from the YODA Project
    Chicago, United States 2018
  • Cancer Screening and Follow-up Care: Too little, Too Much, but Never Too Late
    Chicago, United States 2018
  • Prioritization of patient reported outcomes by women with metastatic breast cancer. Mougalian SS, Aminawung JA, Presley C, Canavan ME, Holland ML, Hu X, Gross CP.
    San Antonio, United States 2018
  • Association between Oncologist Ownership of Imaging Facilities and Utilization: An Analysis of Positron-Emission Tomography (PET) Use in Lymphoma Settings with Variable PET Utility. Huntington SF, Zhu W, Hoag J, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ.
    San Diego, United States 2018
  • Persistent use of extended fractionation palliative radiotherapy for Medicare beneficiaries with metastatic breast cancer: 2011-2014. Yu J, Pollack C, Herrin J, Zhu W, Soulos P, Xu X, Gross C.
    San Antonio, United States 2018
  • State breast density inform mandate laws, use of adjunctive tests and cancer detection following screening mammography. Busch S, Hoag J, Aminawung J, Xu X, Richman I, Soulos P, Kyanko K, Gross C.
    Chicago, United States 2018
  • Early Adoption of Digital Breast Tomosynthesis into Clinical Practice: A National Study. Richman I, Hoag J, Forman H, Busch S, Gross C.
    Denver, United States 2018
  • Adoption of New Cancer Screening Modalities in a Privately Insured Population
    Chicago, United States 2017
  • Irrational Exuberance and the Evolution of Cancer Care in the 21st Century
    Baltimore, United States 2017
  • Understanding Conflicts of Interest – Evolution of a Research Agenda. Or: How I Learned to Stop Worrying and Love Big Pharma
    Baltimore, United States 2017
  • Could Social Contagion Help Us Improve Value in Cancer Care & Research?
    Boston, United States 2017
  • Early Insights from an Academic-Industry Collaboration Unlocking Real-World Clinical Data
    Palo Alto, United States 2017
  • Contagious Knowledge: Social Networks, Open Science, & the Effort to Improve Cancer Outcomes
    New York, United States 2017
  • Stereotactic body radiation therapy for oligometastatic disease: a multi-institutional retrospective survival analysis. Bui D, Magnuson W, Lester-Coll N, Qian J, Ross R, Soulos P, Shafman T, Dosoretz A, Evans S, Yu J, Gross C, Decker R.
    San Diego, United States 2017
  • Racial disparities in the use of programmed death 1 checkpoint inhibitors.
    Chicago, United States 2017
  • Disparities in Next Generation Sequencing in a Population-Based Community Cohort of Patients with Advanced Non-Small Cell Lung Cancer. Presley CJ, Soulos PR, Chiang AC, Longtine JA, Adelson KB, Herbst RS, Nussbaum NC, Sorg R, Abernethy AP, Agarwala V, Gross CP.
    Chicago, United States 2017
  • Physician volume and discontinuation of rituximab during lymphoma treatment. Huntington SF, Long JB, Hoag JR, Wang R, Zeidan AM, Gore S, Ma X, Gross CP, Davidoff AJ.
    Chicago, United States 2017
  • Socioeconomic disparities in needle biopsy prior to breast cancer surgery across physician referral networks. Killelea BK, Herrin J, Soulos PR, Pollack C, Forman H, Yu J, Xu X, Tannenbaum S, Wang S, Oladele C, and Gross CP.
    San Antonio, United States 2016
  • Modern Radiotherapy for Left–Sided Breast Cancer: An Analysis of Mean Heart Dose within Diverse Practice Settings. Hong J, Gross C, Shafman T, Hu X, Yu J, Ross R, Dosoretz A, Park H, Soulos P, Evans S, Finkelstein S.
    Boston, United States 2016
  • Pt-reported QOL aft SBRT vs. modhypofractionation for clin loc prostate ca. Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz A, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, and Yu JB.
    Boston, United States 2016
  • A biologic effect dose ≥105Gy assoc w improved overall survival stage I non-sm cell lung ca patients treated with stereotactic body radiation therapy. Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Dosoretz AP, Finkelstein SE, Shafman TD, Husain ZA, Evans SB, Yu JB, Gross CP, and Decker RH.
    Boston, United States 2016
  • Examining Trends in the CMS Medicare Provider Utilization and Payment Database for Radiation Oncologists. Jairam V, Gross C, Yu J.
    Boston, United States 2016
  • Bone density screening in postmenopausal females with early stage breast cancer on aromatase inhibitors. Stratton J, Hu X, Soulos PR, Davidoff AJ, Pusztai L, Gross CP, Mougalian S.
    Chicago, United States 2016
  • Associations of pre- and post-cancer depression with end-of-life cancer care intensity. Doan K, Levy BR, Gross CP, Wang S.
    Chicago, United States 2016
  • The Impact of Social Contagion on Physician Adoption of Breast Cancer Imaging. Pollack CE, Soulos PR, Herrin J, Xu X, Christakis N, Forman HP, Yu J, Killelea BK, Wang S, Gross CP.
    Chicago, United States 2016
  • Association of Length of Hospice Enrollment with Regional Variation in End-of-Life Healthcare Expenditures. Wang S, Huang S, Hsu SH, Gross CP.
    Chicago, United States 2016
  • Identifying Social Networks for Provider Care: Assessing Stability. Herrin J, Soulos PR, Pollack CE, Gross CP.
    Boston, United States 2016
  • Open Science, Transparency, & Data Sharing
    Washington, United States 2015
  • Yale Open Data Access Project: Overview and Lessons Learned
    London, United Kingdom 2015
  • The Quest for Value in Cancer Care and Research in the US and the UK
    London, United Kingdom 2015
  • Changes in Medicare Supplemental Medical and Drug Coverage Associated with a Health Shock: The Case of Cancer. Davidoff AJ, Gross CP, Soulos PR, Hall J.
    Minneapolis, United States 2015
  • Association Between Supplemental Coverage and Stage at Cancer Diagnosis: New Evidence from SEER-Medicare. Davidoff AJ, Gross CP, Soulos PR, Hall J.
    Minneapolis, United States 2015
  • Trends and regional variation of end-of-life cancer care in the Medicare program. Wang S, Hall J, Pollack C, Adelson K, Bradley E, Long J, Gross CP.
    Chicago, United States 2015
  • Outcomes of adjuvant ACT vs. TC chemotherapy in older women with breast cancer. Mougalian SS, Long JB, Hall J, Adelson K, Abu-Khalaf M, Pusztai L, Gross CP.
    Chicago, United States 2015
  • “The burden upon me”: The complexity of healthcare utilization among Medicare patients undergoing curative treatment for early-stage non-small cell lung cancer. Presley CJ, Soulos PR, Yu JB, Gross CP.
    Chicago, United States 2015
  • Disease-specific costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes. Zeidan AM, Wang R, Davidoff AJ, Gore SD, Gross CP, Ma X.
    Washington, United States 2015
  • Second myeloid malignancy in prostate cancer patients after radiotherapy, a population-based study. Wang R, Zeidan A, Soulos PR, Yu JB, Davidoff AJ, Gore SD, Gross CP, Ma X.
    Washington, United States 2015
  • County-Level Physician Supply and Utilization of Mohs Micrographic Surgery among Medicare Beneficiaries. Maroongroge S, Ross JS, Gross C, Lott JP.
    San Francisco, United States 2015
  • Improving Cancer Outcomes: Can Researchers be Change Agents?
    Chicago, United States 2014
  • Does Adoption of New Technology Improve Cancer Outcomes?
    London, United Kingdom 2014
  • Improving Cancer Outcomes with Big Data
    London, United Kingdom 2014
  • Improving Cancer Outcomes: Is Research the Problem or the Solution
    London, United Kingdom 2014
  • Improving Cancer Outcomes: Is Research the Problem or the Solution
    London, United Kingdom 2014
  • Improving Cancer Outcomes: Is Research the Solution or the Problem
    San Diego, United States 2014
  • The adoption of hypofractionated whole breast irradiation for early-stage breast cancer: A national cancer data base analysis. Wang E, Mougalian SS, Soulos PR, Rutter CE, Evans SB, Haffty BG, Gross CP, Yu JB.
    San Antonio, United States 2014
  • Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Erb CT, Soulos PR, Tanoue L, Gross CP.
    Austin, United States 2014
  • Impact of three decades of screening on racial disparities in cervical cancer incidence. Yang D, Soulos PR, Davis B, Gross CP, Yu JB.
    San Francisco, United States 2014
  • Comparative effectiveness of stereotactic body radiotherapy vs. surgery for stage I non-small cell lung cancer. Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP.
    San Francisco, United States 2014
  • Cardiologist Consultation and Associated Outcomes for Older Women with Heart Failure after Breast Cancer Therapy. Chen J, Long JB, Chen C, Wang SY, Steingart RM, Gross CP.
    Baltimore, United States 2014
  • Cardiovascular Events, Early Discontinuation of Trastuzumab, and Their Impact on Survival. Chen J, Wang SY, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP.
    Baltimore, United States 2014
  • Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment. Graham-Steed TR, Soulos PR, Dearing N, Concato J, Tinetti ME, Gross CP.
    Chicago, United States 2014
  • Estimating the impact of three decades of screening on racial disparities in cervical cancer incidence. Yang D, Soulos PR, Davis B, Gross CP, Yu JB.
    Chicago, United States 2014
  • Diffusion of stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer in the Medicare population, 2007-2009. Yu JB, Soulos PR, Cramer LD, Decker, RH, Kim AW, Gross CP.
    Chicago, United States 2014
  • Surgical Delay for Melanoma among Medicare Beneficiaries. Lott J, Soulos PR, Aminawung J, Gross CP.
    Denver, United States 2014
  • Stereotactic body radiosurgery versus intensity modulated radiotherapy for prostate cancer: Comparison of toxicity. Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP.
    San Francisco, United States 2014
  • Embracing Complexity: Integrating Multimorbidity into the Cancer Disparities Research Framework
    Atlanta, United States 2013
  • Integrating value into the care of older persons with cancer: Rational decisions or rationing care?
    Farmington, United States 2013
  • Association of partial nephrectomy and presence of robotic surgery for kidney cancer in the United States. Kardos SV, Shuch B, Schulam PG, Gross CP, Shah ND, Trinh Q, Smaldone MC, Sun M, Weight CJ, Sammon J, Han LC, Kim SP.
    Bethesda, United States 2013
  • A Clinical Risk Score Predicting Heart Failure and Cardiomyopathy after Adjuvant Trastuzumab Therapy for Breast Cancer. Ezaz G, Long JB, Gross CP, Chen J. A
    Dallas, United States 2013
  • Quality of breast cancer care in the US territories: Insights from the Medicare program. Layne TM, Aminawung J, Soulos PR, Nunez-Smith M, Nunez MA, Jones BA, Wang K, Gross CP.
    Boston, United States 2013
  • Dissemination of New Technologies and Temporal Trends in Curative Therapy for Prostate Cancer Patients with Low Likelihood of Clinical Benefit. Raldow A, Presley CJ, Yu JB, Cramer LD, Soulos PR, Long JB, Makarov DV, Gross CP.
    Atlanta, United States 2013
  • Changes in Early and Late Stage Colorectal Cancer Incidence During the Era of Screening: 1976-2009.
    Atlanta, United States 2013
  • Stereotactic Radiosurgery versus Intensity Modulated Radiotherapy for Prostate Cancer: Comparison of Early Toxicity. Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP.
    Atlanta, United States 2013
  • For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery. Sen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski B, Ross JS, Krumholz HM, Gross CP.
    Chicago, United States 2013
  • Changes in early- and late-stage colorectal cancer incidence during the era of screening: 1976-2009. Yang DX, Gross CP, Yu JB.
    Chicago, United States 2013
  • The Impact of Age and Comorbidity on Cancer Screening
    New York, United States 2012
  • Introducing National Private Insurance Claims Data for Research
    Washington, United States 2012
  • Early Termination of Adjuvant Trastuzumab Associated with Cardiovascular Events in Older Women with Breast Cancer. Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP.
    Los Angeles, United States 2012
  • Comparison of the Level of Evidence Supporting Practice Guidelines in Cancer Care Between Therapeutic Modalities. Buscariollo D, Lloyd S, Gross CP, Makarov DV, Yu YB.
    Boston, United States 2012
  • The Funding of Phase 3 Clinical Trials Examining Radiation Compared with That of Other Modalities. Lloyd S, Buscariollo D, Gross CP, Makarov DV, Yu YB.
    Boston, United States 2012
  • An Assessment of the Collective Efforts of Clinical Trials to Provide Evidence-Based Practice Guidelines in Cancer Care. Lloyd S, Buscariollo D, Gross CP, Makarov DV, Yu YB.
    Boston, United States 2012
  • Temporal Trends in Radiation Modalities Among Older Women with Favorable Risk Breast Cancer. Roberts KB, Soulos PR, Yu JB, Evans SB, Long JB, Gross CP.
    Boston, United States 2012
  • Understanding Costs and Value of Newer Radiation Modalities among Older Women with Breast Cancer. Sen S, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB Chagpar AB, Gross CP.
    Boston, United States 2012
  • Proton Radiotherapy For Prostate Cancer In The Medicare Population: Patterns Of Care And Comparison Of Early Toxicity With Intensity Modulated Radiotherapy.
    Boston, United States 2012
  • Factors associated with life expectancy among older adults receiving palliative chemotherapy. Hurria A, Hardt M, Tew WP, Mohile SG, Owusu C, Gross CP, Gajra A, Lichtman SM, Katheria V, Ramani R, Zavala L, Klepin HD.
    Chicago, United States 2012
  • The evolution of breast cancer screening in the Medicare population: Clinical and economic implications. Killelea BK, Long JB, Ma X, Wang R, Chagpar AB, Ross J, Gross CP.
    Chicago, United States 2012
  • An Assessment of the Collective Efforts of Clinical Trials to Provide Evidence-Based Practice Guidelines in Cancer Care. Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu JB.
    Chicago, United States 2012
  • Anemia and Functional Disability in Older Adults. Owusu C, Tew WP, Hardt M, Mohile SG, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A.
    Chicago, United States 2012
  • Regional variation in treatment costs and survival for elderly patients with myelodysplastic syndromes. Ma X, Wang R, Long JB, Gold HT, Halene S, Gross CP.
    Chicago, United States 2012
  • Patterns of use and short-term complications of breast brachytherapy in the national Medicare population: 2008-2009. Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea BK, Lesnikoski BA, Long JB, Gross CP.
    Chicago, United States 2012
  • . The Relationship among Age, Anxiety, and Depression in Older Adults with Cancer. Weiss T, Nelson CJ, Tew WP, Hardt M, Mohile SG, Owusu C, Klepin HD, Gross CP, Gajra A, Lichtman SM, Ramani R, Katheria V, Zavala L, Hurria A.
    Chicago, United States 2012
  • Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT. Yu JB, Soulos PR, Cramer LD, Roberts KB, Herrin J, Potosky AL, Gross CP.
    Chicago, United States 2012
  • Are bilateral mastectomy rates among older women rising due to preoperative breast MRI? Killelea BK, Long JB, Ma X, Soulos PR, Chagpar AB, Gross CP.
    Phoenix, United States 2012
  • The effect of computer aided detection (CAD) on breast biopsy and breast cancer detection in a Medicare population. Killelea BK, Long JB, Ma X, Wang R, Chagpar AB, Gross CP.
    Phoenix, United States 2012
  • Understanding and decision making about screening colonoscopy for older persons with multimorbidity. Lewis C, Fried T, Ross JS, Aminawung J, Werner L, Kistler C, Tinetti M, McKenzie D, Genao I, Gross CP.
    Orlando, United States 2012
  • The effect of age-specific guidelines on screening older women for cancer. Licurse A, Soulos PR, Quon JL, Gross CP.
    Orlando, United States 2012
  • National utilization patterns of Mohs Micrographic Surgery for malignant melanoma in situ. Viola KV, Gonsalves L, Gross CP, Turner RB.
    Raleigh, United States 2012
  • Management of stage 1 breast cancer for women under the age 65: The influence of regional radiation oncologist and general surgeon services on treatment choice. Aneja S, Smith BD, Wilson LD, Haffty BG, Gross CP, Yu JB.
    Las Vegas, United States 2012
  • Risk of heart failure or cardiomyopathy associated with adjuvant trastuzumab or chemotherapy in older women with breast cancer. Chen J, Long JB, Steingart RM, Gross CP.
    Chicago, United States 2012
  • Incidence of Heart Failure or Cardiomyopathy after Adjuvant Trastuzumab Therapy for Breast Cancer: A SEER-Medicare Analysis. Chen J, Long JB, Steingart RM, Gross CP.
    Chicago, United States 2012
  • The influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer management. Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP.
    San Francisco, United States 2012
  • The influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Yu JB, Aneja S, Makarov DV, Roberts KB, Gross CP.
    San Francisco, United States 2012
  • White Coats, Grass Roots, and Health Reform (Panel Speaker)
    Atlanta, United States 2011
  • Understanding Cancer Screening and Outcomes in an Aging Population
    London, United Kingdom 2011
  • Influence of physician densities and patient characteristics on the decision to treat prostate cancer patients with varying clinical benefit. Aneja S, Makarov DV, Gross CP, Roberts KB, Yu JB.
    Miami, United States 2011
  • Influence of regional radiation oncologist and urologist capacities on treatment choice for prostate cancer. Aneja S, Gross CP, Makarov DV, Roberts KB, Yu JB.
    Miami, United States 2011
  • Are the efforts of current clinical trials involving radiation therapy focused on the evidence gaps in cancer treatment? Lloyd S, Gross CP, Makarov DV, Yu JB.
    Miami, United States 2011
  • Primary dose reduction of chemotherapy in patients older than age 65 with advanced cancer and toxicity outcomes. Ajeet Gajra, Hurria J, Togawa K, Mohile S, Owusu C, Kleipin H, Gross CP, Lichtman S, Bhatia S, Katheria BS, Klapper S, Hansen K, Ramani R, Lachs M Wong FL, Tew W.
    Chicago, United States 2011
  • Do cancer survivors follow screening guidelines better? Chagpar A, Sanft T, Gross CP.
    Chicago, United States 2011
  • Predictors of primary dose reduction (PDR) among patients age 65 and older receiving adjuvant chemotherapy. Kleipin H, Ajeet Gajra, Hurria J, Togawa K, Mohile S, Owusu C, Gross CP, Lichtman S, Bhatia S, Katheria BS, Klapper S, Hansen K, Ramani R, Lachs M Wong FL, Tew W.
    Chicago, United States 2011
  • Racial disparities in prostate cancer treatment: Understanding the contribution of inappropriate care. Presley CJ, Raldow AC, Cramer LD, Soulos PR, Long JB, Makarov DV, Yu JB, Gross CP.
    Chicago, United States 2011
  • Racial disparities in prostate cancer treatment: The contribution of inappropriate care. Presley C, Yu J, Soulos P, Long J, Cramer L, Gross CP.
    Chicago, United States 2011
  • A geographic analysis of the radiation oncology workforce. (2011 Young Oncologist Essay Award – Sanjay Aneja) Aneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts KB, Yu JB.
    Palm Beach, United States 2011
  • A new paradigm in the interpretation of observational studies evaluating postoperative radiation therapy. Park HS, Gross CP, Yu JB.
    Palm Beach, United States 2011
  • Adoption of Invasive Clinical Staging Techniques in Stage IIIA Non-Small Cell Lung Cancer Lags Adoption of Positron Emission Tomography. Vest MT, Tanoue L, Detterbeck F, Gross CP.
    Denver, United States 2011
  • Adoption of invasive clinical staging techniques in stage IIIA non-small cell lung cancer. Vest MT, Tanoue L, Soulos PR, Kim AW, Detterbeck FC, Morgensztern D, Gross CP.
    Denver, United States 2011
  • Head & Neck Cancer(HNC)Patients Undergoing Int Modulated Rad Therpy(IMRT) Have Fewer Subsequent DaysOfHosp(DOH) than Do Patients Undergoing Conventional Rad Therpy(CRT) in the SEER-Medicare Linked Database. Gross CP, Soulos PM, Sharma R, Makarov DV, Decker RJ, Smith BD, Desai RA, Cramer LD, Yu JB.
    San Diego, United States 2011
  • Understanding Comorbidity and Cancer
    Chicago, United States 2010
  • Underrepresentation of Older Persons in Clinical Trials: Implications for Comparative Effectiveness Research
    Chicago, United States 2010
  • Head&NeckCancer(HNC) Patients Undergoing PrimaryRad w IntensityModulatedRadiationTherpy(IMRT) Demonstrate ImprovedOverallSurvival(OS) Comp to Undergo ConventionalRadiationTherapy(CRT) in SEER-Medicare Link Database. YuJB, SoulosPM, SharmaR, MakarovDV, DeckerRJ, SmithBD, DesaiRA, CramerLD, GrossCP
    San Diego, United States 2010
  • . Effect of sex, age and life expectancy on receipt of screening colonoscopy in the Medicare population. Gancayco J, Khiani V, Soulos P, Cramer L, Ross J, Braithwaite S, Genao I, Tinetti M, Gross CP.
    New Orleans, United States 2010
  • Radiology Alone for 5+ Brain Metatases – Expert Opinion Survey. Knisely, J, Yamamoto M, Chiang, V, Castrucci W, Gross C, Jokura H.
    Athens, Greece 2010
  • Burden of comorbidity among Medicare beneficiaries with heart failure. Ahluwalia SC, Gross CP, Chaudhry SI, Fried TR.
    Minneapolis, United States 2010
  • Comorbidity and mortality in advanced heart failure. Ahluwalia SC, Gross CP, Chaudhrey SI, Fried TR.
    Minneapolis, United States 2010
  • Renal ultrasound in the evaluation of acute kidney injury: Developing a risk stratification framework. Licurse A, Formica R, Forman H, Parikh C, Dzuira J, Makarov D, Kim M, Gross CP.
    Minneapolis, United States 2010
  • Conflict of Interest in Clinical Research: An Empirical Overview
    Washington, United States 2009
  • Focusing on the Big Picture: Integrating Chronic Illness Burden into Decisions about Cancer Screening and Treatment
    Boston, United States 2009
  • Care of the Cancer Survivor
    New London, United States 2009
  • Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multi-center study. Hurria A, Mohile S, Lichtman S, Owusu C, Klepin H, Gross CP, Hansen K, Klapper S, Togawa K, Tew W.
    Orlando, United States 2009
  • The effect of the 2003 EMTALA Update on trauma care. Mitesh R, Epstein A, Martin E, Gross CP.
    Chicago, United States 2009
  • The shortage of on-call coverage: understanding the issue. Rao M, Lerro C, Gross CP.
    Chicago, United States 2009
  • The effect of the 2003 EMTALA Update on trauma care. Rao M, Epstein A, Martin E, Gross CP.
    New Orleans, United States 2009
  • The shortage of on-call coverage: understanding the issue. Rao M, Lerro C, Gross CP.
    New Orleans, United States 2009
  • Regional variation in total cost of radical prostatectomy: evidence from the 2004 Healthcare Cost and Utilization Project Nationwide Inpatient Sample. Makarov D, Loeb S, Landman AB, Nielsen ME, Gross CP, Penson DF, Desai RA.
    Chicago, United States 2009
  • Validating the Partin tables using the NCI SEER Database. Yu J, Makarhov D, Partin J, Gross CP.
    Chicago, United States 2009
  • Radiosurgery practitioner attitudes regarding the use of stereotactic radiosurgery alone for oligometastatic brain metastases. Knisely JPS, Castrucci WA, Gross CP, Chiang VL.
    Mont-Tremblant, Canada 2009
  • Conflict of Interest in Medicine: Is There a Policy Solution?
    New York, United States 2007
  • Conflict of Interest in Clinical Research: An Empirical Overview
    Washington, United States 2007
  • Impact of Third Party Payer Policies on Clinical Trial Enrollment: What does the Evidence Say
    Baltimore, United States 2007
  • Financial Conflict of Interest and Clinical Research: Impact on Scientific Integrity
    Bethesda, United States 2007
  • The Practicing Oncologist-Pharmaceutical Industry Relationship: What are the Ethical Bounds?
    Chicago, United States 2007
  • Multi-morbidity and Cancer Outcomes: An Integrated Approach
    Detroit, United States 2007
  • Conflict of Interest in Clinical Research: Update for 2007
    Bethesda, United States 2007
  • Primary Care of the Diabetic Patient
    Bridgeport, United States 2007
  • Financial Conflict of Interest and Clinical Research: Impact on Scientific Integrity
    Bethesda, United States 2006
  • Conflict of Interest in Clinical Research
    Bethesda, United States 2006
  • Race and Clinical Trial Enrollment: What do the Data Say?
    Washington, United States 2006
  • Cancer in Underserved Populations: Scope of the Problem in Connecticut
    New Haven, United States 2006
  • Financial Conflict of Interest and Clinical Research: Impact on Scientific Integrity
    Bethesda, United States 2005
  • Financial Conflict of Interest and Clinical Research: Beware the Medical Industrial Complex
    Bethesda, United States 2005
  • Genetics in Primary Care: A Challenge for the New Millennium
    New Haven, United States 2005
  • Financial Conflict of Interest and Clinical Research: Where Should We Go From Here?
    New York, United States 2005
  • Financial Conflict of Interest and Medical Research: Beware the Medical Industrial Complex
    New Orleans, United States 2004
  • Industry-Sponsored Research and the New PhRMA Guidelines – A Perspective from an Academic Medical Center
    Pittsburgh, United States 2003
  • Financial Conflict of Interest in Scientific Publication
    Pittsburgh, United States 2003
  • Barriers to Participation in Cancer Research: Insights from National Cancer Institute Enrollment Data
    New York, United States 2003
  • Financial Conflict of Interest and Medical Research: Beware the Medical Industrial Complex
    Washington, United States 2003
  • Using Disease Burden to Guide Allocation Decisions: Pros and Cons
    Bethesda, United States 1999

Honors & Recognition

AwardAwarding OrganizationDate
Visiting ProfessorJohns Hopkins School of Medicine2017
Paper of the Year, 2001. Gross CP, Steiner CA, Bass EB, Powe NR. Relation between prepublication release of clinical trial results and the practice of carotid endarterectomy. JAMA. 2000; 284:2886-93Academy for Health Services Research and Health Policy2015
American Society for Radiation Oncology Annual Mtg Resident Digital Poster Discussion Recognition AwardAmerican Society for Radiation Oncology2013
Population Sciences Research PrizeYale Cancer Center2013
Mid-Career Research Mentorship AwardSociety of General Internal Medicine2012
FellowAmerican College of Physicians2010
Connecticut Quality Improvement Partnership Silver Innovation PrizeConnecticut Quality Improvement Partnership2006
Joseph A. Zaccagnino Patient Safety and Clinical Quality AwardYale-New Haven Hospital2006
Paul Beeson Physician Faculty Scholars in Aging Research AwardNational Institute on Aging/ American Federation for Aging Research2004
Ralph I. Horwitz LecturerDepartment of Medicine2004
Clinical Investigator AwardSociety of General Internal Medicine, New England Region2003

Professional Service

OrganizationRoleDate
Society of General Internal Medicine, Scientific Abstract Selection Committee (Clinical Epi/Effectiveness)Co-Chair2020 - Present
Medicare Contractor Advisory Committee, MedicareCommittee Member2019
NCCN Institutional Representative for Young Investigator AwardReviewer2019
American Society for Clinical InvestigationMember2018
Yale School of Public Health Standing Appointments and Advisory CommitteeCommittee Member2018 - Present
Yale Information Technology Services Advisory CommitteeCommittee Member2018 - Present
Yale-New Haven Hospital Primary Care Center Ambulatory Opioid Safety Task ForceChair2018 - Present
American Society for Clinical InvestigationMember2018 - Present
American Cancer Society: Health Policy and Health Services Research (CPHPS) Review CommitteeCommittee Member2017 - 2019
Yale School of Public Health, Search Committee for DeanCommittee Member2017
Yale University Senior Appointments & Promotions CommitteeCommittee Member2017 - Present
Dutch Breast Cancer FoundationAd-hoc reviewer2015
Wellcome Trust/DBT India Alliance FellowshipAd-hoc reviewer2015
Provocative Questions Initiative, National Cancer InstituteAd-hoc Member2014
Society of General Internal Medicine, Mid-Career Mentorship Award Selection CommitteeCommittee Member2013
American Society of Clinical OncologyMember2012 - Present
Yale Medical Group Epic Clinical Leadership CommitteeCommittee Member2011 - 2014
Yale School of Public Health, Cancer Outcomes Search CommitteeChair2011 - 2012
(Editorial Board Member), Journal of Geriatric OncologyGuest Editor2011 - Present
American College of PhysiciansFellow2011 - Present
Robert Wood Johnson Clinical Scholars Program, Annual Meeting Planning CommitteeChair2010
Health Services Outcomes and Delivery (HSOD), National Institutes of HealthAd-hoc Member2010
Pennsylvania State Cancer Research ConsortiumAd-hoc reviewer2010
Yale-New Haven Hospital Department of Community Health, Clinical Quality Improvement Working Group CommitteeCommittee Member2007 - 2009
CALGB Health Services Sub-Committee MeetingParticipant2007
Cadre Member, Cancer and Leukemia Group B (CALGB) Health Services Sub-CommitteeMember2007
Scottish Executive Health Department, Chief Scientist OfficeAd-hoc reviewer2007
Cancer Research UK, Population and Behavioral Sciences CommitteeGrant Reviewer2007
Medicare Coverage Advisory Committee on Clinical Trial PolicyExpert Panel Member2006
Robert Wood Johnson Clinical Scholars Program Annual Meeting Planning CommitteeCo-Chair2006
American College of PhysiciansMember2006 - Present
Society of General Internal Medicine, New England Regional Clinical Investigator Award Selection CommitteeCommittee Member2005
National Institute of Neurologic Disease and Stroke: Research on Research Integrity Special Emphasis Study SectionPanelParticipant2004
Johns Hopkins Evidence Practice Center Report: Knowledge and Access to Information on Recruitment of Medically Underserved Populations to Clinical TrialsExternal Reviewer2004
Society of General Internal Medicine, New England Regional Clinical Investigator Award Selection CommitteeChair2004
Expert Reviewer, Asociazone Nationale Medicine Cardiology Ospedalieri, Scientific CommitteeReviewer2003
Yale University General Internal Medicine Section Chief Search CommitteeCommittee Member2000 - 2002
Yale-New Haven Hospital Department of Community Health QI CommitteeDirector1999 - 2004
Community Health Care Van (Monthly)Physician1999 - 2004
New England Journal of MedicineReviewer1999 - Present
Medical CareReviewer1999 - Present
Health Services ResearchReviewer1999 - Present
Journal of Clinical EpidemiologyReviewer1999 - Present
Journal of General Internal MedicineReviewer1999 - Present
American Journal of GastroenterologyReviewer1999 - Present
Annals of Internal MedicineReviewer1999 - Present
British Medical JournalReviewer1999 - Present
Journal of the American Medical Association, JAMA-Internal Medicine, JAMA-OncologyReviewer1999 - Present
Canadian Medical Association JournalReviewer1999 - Present
American Journal of MedicineReviewer1999 - Present
Journal of Clinical Oncology (JNCI)Reviewer1999 - Present
Australian Medical JournalReviewer1999 - Present
Clinical Colorectal CancerReviewer1999 - Present
(Consulting Editor), The Johns Hopkins Family Health BookGuest Editor1998
Society of General Internal MedicineMember1997 - Present

Departments & Organizations

Edit Profile